Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v6-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-04-13 | 2022-04-13 |
| Drug Identification Number | 02403544 | 02403544 |
| Brand name | COLISTIMETHATE FOR INJECTION | COLISTIMETHATE FOR INJECTION |
| Common or Proper name | Colistimethate for Injection 150 mg SD Vial 6.5 mL | Colistimethate for Injection 150 mg SD Vial 6.5 mL |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | COLISTIN | COLISTIN |
| Strength(s) | 150MG | 150MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 6.5 mL | 6.5 mL |
| ATC code | J01XB | J01XB |
| ATC description | OTHER ANTIBACTERIALS | OTHER ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-12-14 | 2021-12-14 |
| Actual start date | ||
| Estimated end date | 2022-02-21 | 2022-02-21 |
| Actual end date | 2022-02-22 | 2022-02-22 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays we will be extending the backorder on our Colistimethate for Injection 150 mg SD Vial 6.5 mL until February 21, 2022. Sterimax is an alternate supplier of Colistimethate for Injection and have been informed of our impending supply interruption. | Fresenius Kabi Canada regrets to advise that due to further production delays we will be extending the backorder on our Colistimethate for Injection 150 mg SD Vial 6.5 mL until February 21, 2022. Sterimax is an alternate supplier of Colistimethate for Injection and have been informed of our impending supply interruption. |
| Health Canada comments |